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CLINICAL RESEARCH

SARS-CoV-2 Infects Human
Engineered Heart Tissues and Models
COVID-19 Myocarditis
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VISUAL ABSTRACT

HIGHLIGHTS
 SARS-CoV-2 directly infects
cardiomyocytes in patients with COVID-19
myocarditis and does not infect cardiac
macrophages, ﬁbroblasts, or endothelial
cells.
 COVID-19 myocarditis is characterized by
a myeloid-rich inﬂammatory inﬁltrate.
 SARS-CoV-2 infects cardiomyocytes
through an ACE2 and endosomal cysteine
protease dependent pathway.
 Infection of hPSC-derived cardiomyocytes
and engineered heart tissues show that
cytokine production, sarcomere disassembly, and cell death were a direct
consequence of cardiomyocyte infection.
 SARS-CoV-2 reduces cardiomyocyte
contractility through sarcomere
breakdown and cardiomyocyte cell death.
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ABBREVIATIONS

SUMMARY

AND ACRONYMS
ACE2 = angiotensin converting

There is ongoing debate as to whether cardiac complications of coronavirus disease-2019 (COVID-19) result

enzyme 2

from myocardial viral infection or are secondary to systemic inﬂammation and/or thrombosis. We provide

COVID-19 = coronavirus

evidence that cardiomyocytes are infected in patients with COVID-19 myocarditis and are susceptible to severe

disease-2019

acute respiratory syndrome coronavirus 2. We establish an engineered heart tissue model of COVID-19

EHT = engineered heart tissues

myocardial pathology, deﬁne mechanisms of viral pathogenesis, and demonstrate that cardiomyocyte severe

hPSC = human pluripotent

acute respiratory syndrome coronavirus 2 infection results in contractile deﬁcits, cytokine production, sarco-

stem cell(s)

mere disassembly, and cell death. These ﬁndings implicate direct infection of cardiomyocytes in the patho-

LV = left ventricle

genesis of COVID-19 myocardial pathology and provides a model system to study this emerging disease.

SARS-CoV-2 = severe acute

(J Am Coll Cardiol Basic Trans Science 2021;6:331–45) © 2021 The Authors. Published by Elsevier on behalf of

respiratory syndrome-

the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND

coronavirus-2

license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

S

evere acute respiratory syndrome-coronavirus-2

are lacking. Furthermore, there are few animal

(SARS-CoV-2) is the cause of the ongoing corona-

models

virus disease-2019 (COVID-19) pandemic. Epide-

observed in SARS-CoV-2–infected humans (9). The

to

study

cardiovascular

complications

pre-existing

most commonly used laboratory animal model, the

cardiovascular disease as a risk factor for the develop-

mouse, is not susceptible to SARS-CoV-2 infection

ment of severe COVID-19 and mortality [reviewed in

due to poor afﬁnity of the viral spike protein for

Madjid et al. (1)]. Cardiovascular manifestations of

murine angiotensin converting enzyme 2 (ACE2).

COVID-19 include elevated troponin, reduced left ven-

Transgenic mice that express human ACE2 under the

tricular (LV) systolic function, and arrhythmias. Cardiac

control of the cytokeratin 18 promotor do not reca-

complications occur in 20% to 44% of hospitalized pa-

pitulate ACE2 expression within the human cardio-

tients, and constitute an independent risk factor for

vascular system (10–12). Therefore, there is a critical

COVID-19 mortality (1–4). Cardiac magnetic resonance

need to develop robust model systems that enable the

imaging studies have suggested that persistent myocar-

investigation of the cardiovascular complications of

dial injury may be more common than appreciated and

COVID-19.

miological

studies

have

identiﬁed

occurs in less severe forms of COVID-19 (5–7). The mech-

We

used

human

myocardial

specimens

and

anistic basis by which SARS-CoV-2 results in cardiac

devised an engineered heart tissue (EHT) model of

dysfunction remains obscure and it is unclear whether

COVID-19 myocarditis to test the hypothesis that

these effects are a result of myocardial infection or a sys-

SARS-CoV-2 promotes cardiac pathology by infecting

temic inﬂammatory response to extracardiac infection

cardiomyocytes and activating local immune re-

(8).

sponses. EHT provide unique advantages as model

Investigation of the cardiac manifestations of

systems for studying COVID-19 cardiac pathology

COVID-19 has remained challenging. Rigorous ana-

because they generate contractile force, display

lyses of cardiac tissue obtained from affected patients

electrical coupling, promote maturation of human
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F I G U R E 1 Specimens From Patients With Severe COVID-19 Myocarditis Show Evidence of SARS-CoV-2 Cardiomyocyte Infection
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pluripotent stem cell (hPSC)–derived cardiomyocytes,

displayed for parametric tests and nonparametric

and have cellular organization that mimics myocar-

tests, respectively.

dial tissue (12–14). These studies show that cardiomyocytes

are

a

target

of

SARS-CoV-2,

link

RESULTS

cardiomyocyte infection to disease pathogenesis, and
establish EHT as an experimentally tractable model of

EVIDENCE OF CARDIOMYOCYTE INFECTION IN SEVERE

COVID-19 myocardial pathology.

COVID-19 MYOCARDITIS. The pathology of COVID-19

myocarditis remains poorly understood. We ob-

METHODS

tained autopsy and endomyocardial biopsy specimens from 4 subjects with SARS-CoV-2 infection and

A detailed methods section, including Supplemental

clinical diagnoses of myocarditis. Myocardial injury

Tables 1 and 2, is in the Supplemental Appendix.

and LV systolic dysfunction were present in each case

BIOSAFETY. This study was approved by the IRB of

(Supplemental

Washington University Medical School. All work with

showed no evidence of luminal stenosis or throm-

infectious SARS-CoV-2 was performed in a biosafety

bosis. The presence of SARS-CoV-2 RNA from naso-

Table

angiography

pharyngeal

air purifying respirator.

polymerase chain reaction (PCR) testing.

SARS-CoV-2 was obtained from the United States
Centers for Disease Control. Information on the
NeonGreen SARS-CoV-2-NeonGreen virus was discussed in Xie et al. (13). All infections were performed
at a multiplicity of infection (MOI) of 0.1.
hPSC

CARDIOMYOCYTE

DIFFERENTIATION

AND

EHTs. Stem cells were differentiated by temporal

manipulation of Wnt signaling and metabolic selection.

EHTs

dimethylsiloxane
Technologies,

were
(PDMS)

Hamburg,

assembled

in

poly-

casting

molds

(EHT

Germany)

from

hPSC-

derived cardiomyocytes, ﬁbroblasts, and/or macrophages. EHTs were inoculated with SARS-CoV-2 at
least 7 days after tissue seeding.

was

Coronary

level 3 facility by personnel equipped with a powered
VIRUSES. The 2019n-CoV/USA_WA1/2019 isolate of

samples

3).

conﬁrmed

by

clinical

Postmortem microscopic examination of the LV
myocardium showed areas of cardiomyocyte necrosis
and degenerative vacuolization of cardiomyocyte
cytoplasm accompanied by a mononuclear cell inﬁltrate (Figure 1A). These changes were distinct from
postmortem autolytic changes. Examination of the
coronary arteries from COVID-19 myocarditis autopsy
cases showed nonobstructive mild atherosclerotic
changes, consistent with angiogram ﬁndings. There
was no evidence of microvascular injury or thromboembolic events. Autopsy heart samples from subjects with metastatic carcinoma and an inherited
neurodegenerative disease with similar tissue procurement times were included as negative controls.
SARS-CoV-2 spike and nucleocapsid RNA was
detected within the myocardium of each COVID-19

STATISTICAL ANALYSIS. Statistical tests were cho-

myocarditis subject. Viral transcripts were located in

sen based on accepted standards. The Kolmogorov-

cytoplasmic and perinuclear locations within cells

Smirnov test was used to test for normality. Para-

that were morphologically consistent with car-

metric

(Student

t

test,

analysis

of

variance

diomyocytes (Figure 1B). Viral transcripts were also

[ANOVA]) and nonparametric (Mann-Whitney test)

present lung airway epithelial cells and rare myocar-

statistical methods were used when appropriate.

dial

Statistical signiﬁcance was assigned when p values

Figure

were <0.05 using Prism Version 8 (GraphPad, San

nucleocapsid protein showed presence of viral pro-

Diego, California). Speciﬁc tests are indicated in the

tein in cardiomyocytes (Figure 1C). The immune cell

ﬁgure legends. Mean values and median values are

inﬁltrate was characterized by accumulation of an

adipocytes
1).

and

pericytes

Immunostaining

for

(Supplemental
the

SARS-CoV-2

F I G U R E 1 Continued

(A) Hematoxylin and eosin staining of cardiac autopsy (anterior left ventricular wall) and biopsy samples (right ventricular septum) from subjects without coronavirus
disease-2019 (COVID-19) (control case) and patients with severe COVID-19 myocarditis (case 1-4). (B) In situ hybridization for severe acute respiratory syndromecoronavirus-2 (SARS-CoV-2) spike and nucleocapsid RNA (red). Hematoxylin: blue. The arrows denote viral RNA staining in cells with cardiomyocyte morphology. (C)
Immunostaining of control and COVID-19 myocarditis cardiac autopsy tissue for SARS-CoV-2 nucleocapsid (white) and cardiac actin (red). DAPI: blue. The arrows
denote nucleocapsid staining in cardiomyocytes. (D) Immunostaining of control and COVID-19 myocarditis specimens for CD68 (green) and CCR2 (red). DAPI: blue.
(E) Immunostaining of control and COVID-19 myocarditis tissue for CD3 (brown). Hematoxylin: blue. DAPI ¼ 40 ,6-diamidino-2-phenylindole.
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F I G U R E 2 SARS-CoV-2 Infects Cardiomyocytes
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CCR2 -

CCR2 þ

macrophages

recombinant SARS-CoV-2 clone containing a Neon-

(Figure 1D). Minimal T-cell inﬁltration was noted

Green ﬂuorescent reporter (SARS-CoV-2-NeonGreen)

(Figure 1E). Macrophage abundance was highest in

(13). NeonGreen is expressed from a viral subgenomic

areas of cardiomyocyte injury as depicted by com-

RNA, indicative of active viral replication. Primary

plement deposition (C4d staining, Spearman r ¼ 0.86,

human cardiac ﬁbroblasts, endothelial cells, and

p ¼ 0.0005), a pathological marker of cardiomyocyte

macrophages were not permissive to SARS-CoV-2

cell death (14–16) (Supplemental Figure 1). These ob-

infection (Supplemental Figures 3 to 5). hPSC-

servations suggest that SARS-CoV-2 can infect the

derived endothelial cells and cardiac ﬁbroblasts

human heart and may contribute to cardiomyocyte

were also not susceptible to infection. In contrast, 2

cell death and myocardial inﬂammation.

independent lines of hPSC-derived cardiomyocytes

SARS-CoV-2 TROPISM IN THE HUMAN HEART. ACE2

were permissive to SARS-CoV-2 infection. Undiffer-

serves as a cell-surface receptor for SARS-CoV-2

entiated hPSC lines did not show evidence of infec-

through interactions with the spike protein (17,18).

tion

Consistent with prior reports, we detected ACE2

cardiomyocyte infection showed rapid production of

mRNA expression in the human heart across the

infectious virus with peak titers on day 3 post-

spectrum of age increasing in heart failure (19,20).

inoculation (Figure 2C).

admixture

of

and

(Supplemental

Figure

5).

hPSC-derived

ACE2 mRNA was expressed in cardiomyocytes with

We examined the relationship between viral

signiﬁcant variation in ACE2 protein expression be-

replication and cell death. NeonGreen-positive car-

tween individual cardiomyocytes. hPSC-derived car-

diomyocytes peaked at day 3 post-inoculation. hPSC-

diomyocytes and EHTs expressed ACE2 mRNA and

derived cardiomyocyte cell death was observed
beginning 4 to 5 days post-inoculation (Figure 2D)

protein (Supplemental Figures 2 and 3).
To

determine

the

susceptibility

of

different

indicating that viral infection precedes cell death.

myocardial cell types to SARS-CoV-2 infection, we

SARS-CoV-2–infected

inoculated

car-

characteristics of cytopathic effect, cellular rounding,

combinations

of

hPSC-derived

cardiomyocytes

displayed

diomyocytes, ﬁbroblasts, and macrophages with

clumping, and syncytium formation. Distortion of

wild-type SARS-CoV-2 (USA_WA1/2019). We analyzed

cellular morphology was evident by day 4 post-

tissue culture supernatants for production of infec-

inoculation and cultures contained largely dead

tious virus and measured intracellular viral RNA

cells and debris by days 5 to 6 post-inoculation

transcript levels at 3 days post-inoculation. These

(Figure 2E).

virus

To examine whether cardiomyocytes are a target of

(Figure 2A) and viral RNA (Figure 2B) in cultures that

SARS-CoV-2 in a simulated cardiac environment, we

contained hPSC-derived cardiomyocytes. Cultures

infected 2-dimensional tissues assembled with hPSC-

assays

revealed

production

of

infectious

lacking hPSC-derived cardiomyocytes contained viral

derived cardiomyocytes (80%), ﬁbroblasts (10%), and

loads that were equivalent to media-only controls.

macrophages (10%) with SARS-CoV-2-NeonGreen.

To verify cardiomyocyte selective tropism, we
inoculated human cardiac stromal populations with a

Flow cytometry performed 3 days following infection
revealed

NeonGreen

expression

only

F I G U R E 2 Continued

(A) Focus-forming assay measuring production of infectious virus from human pluripotent stem cell (hPSC)–derived cardiomyocytes (CM), ﬁbroblasts (Fb), and
macrophages (Mac) inoculated with SARS-CoV-2 (multiplicity of infection [MOI], 0.1). Media only denotes wells that contain no cells. Assays were performed 3 days
following inoculation. Dashed line indicates limit of assay detection. (B) Quantitative real-time polymerase chain reaction (RT-PCR) showing viral N-gene copies in
cultures containing CM, Fb, and Macs inoculated with SARS-CoV-2 (MOI 0.1). RNA was collected 3 days post-inoculation (n ¼ 5 per group). (C) Focus-forming assay
measuring infectious SARS-CoV-2 (black line indicates wild-type; green line indicates NeonGreen) in supernatant of hPSC-derived cardiomyocytes over time
following inoculation (MOI 0.1). A dashed line indicates the limit of detection (n ¼ 4 per group). (D) Two-dimensional cultures of hPSC-derived cardiomyocytes were
inoculated with SARS-CoV-2 (MOI 0.1) and analyzed for viability (Zombie-Violet) and infection (NeonGreen) as a function of time by ﬂow cytometry. Right plot shows
viability of NeonGreen-positive cells (n ¼ 4 per group). (A–D) Mean values are plotted and error bars denote standard error of the mean. (E) Brightﬁeld microscopy
showing cytopathic effect in hPSC-derived cardiomyocytes infected with SARS-CoV-2 (MOI 0.1). Representative images from 5 individual samples. (F) Flow cytometry
of 2-dimensional tissues containing CM and Fb (left) or CM, Fb, and Mac (right) harvested on day 3 following mock infection or inoculation with SARS-CoV-2 (MOI 0.1).
Representative plot from 4 independent samples. Cardiomyocytes (CD90-CD14-) showed prominent NeonGreen ﬂuorescence (green overlay). NeonGreen signal was
not detected in ﬁbroblasts (CD90þCD14-) or macrophages (CD90-CD14þ). (G) Quantiﬁcation of NeonGreen-positive cells from 2-dimensional tissues containing
hPSC-cardiomyocytes and ﬁbroblasts or hPSC-cardiomyocytes, ﬁbroblasts, and macrophages (n ¼ 4 per group). Bars denotes median value. *p < 0.05 compared to
mock infection (Mann-Whitney test). (H) Transmission electron microscopy micrographs of cardiomyocytes in 2-dimensional tissues infected with either mock or SARSCoV-2 (MOI 0.1). Tissues were harvested on day 3 post-inoculation. Viral budding (blue arrow) and endosomal compartments ﬁlled with virions (black arrow) are
denoted. Scale bars in insets are 100 nm. Representative image from 4 independent samples. FFU ¼ focus forming units; other abbreviation as in Figure 1.
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CD90- CD14 - TNNT2 þ cardiomyocytes. NeonGreen was

displayed

not detected in CD90þ ﬁbroblasts or CD14 þ macro-

expressed genes. Cell types that did not support viral

the

greatest

overlap

phages (Figures 2F, 2G and Supplemental Figure 6).

replication
showed

tissues performed 3 days post-inoculation showed

(Figure 3D), suggesting that SARS-CoV-2 virions

the presence of coronavirus particles within infected

stimulate host gene expression in the absence of

hPSC-derived cardiomyocytes. Micrographs revealed

direct viral infection. Pathway analysis revealed that

structural features of coronaviruses including the

infected

presence of a trilaminar envelope and characteristic

dimensional co-culture tissues showed upregulation

cross-sections through the nucleocapsid (Figure 2H)

of genes associated with immune cell activation,

(21,22). Virions were identiﬁed within perinuclear

stress-induced transcription, and responses to viral

endosomal-like

car-

pathogens. Genes associated with muscle contrac-

diomyocytes. We observed various stages of virion

tion, metabolism, oxidative phosphorylation, and

assembly including budding from intracellular mem-

mitochondrial

branes. Virions were not detected in mock-infected

(Figures

cardiomyocytes.

expressed in macrophages and ﬁbroblasts were

of

hPSC-derived

and

differentially

Transmission electron microscopy of 2-dimensional

structures

(ﬁbroblasts

in

differentially

hPSC-derived

3E

3F).

host

cardiomyocytes

function
and

macrophages)

expressed

were

Host

also
genes

and

2-

downregulated

genes

differentially

associated with pathways involved in innate immune
RNA

SEQUENCING

TRANSCRIPTION

IDENTIFIED

AND

ROBUST

ACTIVATION

OF

VIRAL
INNATE

cell activation, migration, and cytokine responses
(Figures 3G and 3H).

IMMUNE RESPONSES. To examine viral transcription

Speciﬁc genes downregulated in infected hPSC-

and the host immune response to SARS-CoV-2 infec-

derived cardiomyocytes and 2-dimensional tissues

tion, we performed RNA sequencing. Cultures con-

(Figure 3I) included components of the electron

taining

transport chain (adenosine triphosphate synthase,

either

ﬁbroblasts,

hPSC-derived

or

mock-

mitochondrial cytochrome C oxidase, and nicotin-

infected or inoculated with SARS-CoV-2. We also

amide adenine dinucleotide phosphate dehydroge-

examined 2-dimensional tissues assembled with 80%

nase) and metabolic enzymes (glycerol-3-phosphate

cardiomyocytes, 10% ﬁbroblasts, and 10% macro-

dehydrogenase, pyruvate dehydrogenase, and succi-

phages. Cells and tissues were harvested on day 3

nate dehydrogenase complex). PDK4, an inhibitor of

post-inoculation.

reduction

pyruvate dehydrogenase, was upregulated in infected

analysis revealed separation between experimental

hPSC-derived cardiomyocytes and 2-dimensional tis-

groups consistent with their distinct cellular compo-

sues.

sition

car-

including cardiac actin, troponins, myosin light and

diomyocytes and 2-dimensional tissues contained

heavy chains, desmin, phospholamban, and calse-

abundant viral genomic and subgenomic RNAs iden-

questrin

tiﬁed based on the presence of 5’ leader sequences

dimensional tissues. ACE2 expression was dimin-

(Figure 3B and Supplemental Figure 7) (23).

ished in infected cardiomyocytes and 2-dimensional

(Figure

macrophages

cardiomyocytes,

were

either

Multidimensionality

3A).

Infected

hPSC-derived

Components

were

of

the

contractile

downregulated

in

apparatus

infected

2-

Numerous host genes were differentially regulated

tissues. Infected hPSC-derived cardiomyocytes and

upon SARS-CoV-2 infection in each of the examined

2-dimensional tissues displayed upregulation of

cell types and 2-dimensional tissues (Figure 3C).

innate immune mediators including IFNB1 and

Conditions that supported viral replication (hPSC-

interferon (IFN)– stimulated genes (IFIT1, IFIT2,

derived cardiomyocytes and 2-dimensional tissues)

IFIT3, ISG15, MX1, and OAS1), early response genes

F I G U R E 3 Continued

(A) MDS plot of RNA sequencing data obtained from mock and SARS-CoV-2–infected (MOI 0.1) hPSC-derived CMs, Fbs, Macs, and 2-dimensional tissues (CM þ Fb þ
Mac). Cells and tissues were harvested on day 3 post-inoculation (n ¼ 5 per group). (B) Heatmap of SARS-CoV-2 viral gene expression. Color scale denotes absolute
expression as log2 counts per million reads (CPM) (scale: blue ¼ 0, red ¼ 15). (C) Volcano plots showing differentially expressed genes between mock and SARS-CoV-2–
infected conditions. Black dots indicate no signiﬁcant change, red dots indicate upregulated during infection (log2 fold change>2, FDR p < 0.05), and blue dots
indicate downregulated during infection (log2 fold change<2, FDR p < 0.05). Data points correspond to individual transcripts. (D) Venn diagram of genes upregulated and downregulated in each cell type and tissues. Differential expression is based on change relative to corresponding uninfected (mock) samples. (E to H) Gene
ontology (GO) pathway analysis of CM (E), CM þ Fb þ Mac (F), Mac (G) and Fib (H) showing top 5 upregulated (red) and downregulated (blue) pathways in SARS-CoV2–infected samples compared to mock. Color indicates log2 fold change (log2FC). (I) Heat maps of selected differentially expressed genes implicated in metabolism
(left), contractile apparatus (center), and immune response (right). CM and tissues (CM þ Mac þ Fb) are displayed. Color scale denotes relative gene expression (high
red, low blue) across cell types and conditions. ATP ¼ adenosine triphosphate; FDR ¼ false discovery rate; IL ¼ interleukin. other abbreviations as in Figures 1 and 2.
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F I G U R E 4 EHTs Recapitulate Aspects of COVID-19 Myocarditis

(A) Hematoxylin and eosin (H&E)–stained sections of 3-dimensional engineered heart tissue (EHT) consisting of hPSC-derived CM, Fbs, and
Macs 5 days following mock infection or inoculation with SARS-CoV-2 (MOI 0.1). Insets are high-magniﬁcation images of the boxed areas.
Representative images from 4 independent samples. (B) Immunostaining of mock or SARS-CoV-2–infected 3-dimensional EHTs for sarcomeric
actin (cardiomyocytes, red), CD68 (macrophages, green), and nucleocapsid protein (white). EHTs were harvested 5 days post-inoculation.
Blue: DAPI. Representative images from 4 independent samples. (C) Quantitative RT-PCR of SARS-CoV-2 N-gene expression in EHTs
consisting of hPSC-derived CM, Fb, and/or Macs. EHTs were either mock infected or inoculated with SARS-CoV-2 (MOI 0.1) and harvested
5 days post-inoculation. Error bars denote SE of the mean. Dotted line: limit of detection. *p < 0.05 compared to uninfected control (mock,
Student t test test). (D) In situ hybridization for SARS-CoV-2 spike RNA sense and antisense strands (red) in EHTs 5 days after mock or SARSCoV-2 infection (MOI 0.1). Blue: hematoxylin. Representative images from 4 independent specimens. Insets are high magniﬁcation images
of the boxed areas. (E) Spontaneous beating displacement traces for infected and uninfected EHTs on day 5 post-infection. (F) Displacement
(relative to uninfected mock condition) generated by spontaneous beating of EHTs as a function of time following inoculation with SARS-CoV2 (MOI 0.1). Each data point represents a mean value from 4 to 7 independent samples, error bars denote SE of the mean. (G) Quantiﬁcation
of absolute displacement (left) and contraction speed (right) generated by spontaneous beating of EHTs 5 days following mock or SARSCoV-2 infection (MOI 0.1). Error bars represent SE of the mean; *p < 0.05 compared to mock (Student’s t-test test). Abbreviations as in
Figures 1 and 2.
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(FOS), and cytokines (TNF). Consistent with a greater

or macrophages (Supplemental Figure 8). To deter-

innate immune response in 2-dimensional tissues,

mine whether SARS-CoV-2 enters cardiomyocytes

several chemokines (CCL3, CCL4, CCL7, CCL8, and

through an endosomal or plasma membrane route, we

CXCL8) and cytokines (IL1B, IL6, and CSF3) were

inoculated hPSC-derived cardiomyocytes with SARS-

selectively upregulated in infected 2-dimensional

CoV-2–NeonGreen

tissues. Macrophages and ﬁbroblasts contributed to

endosomal cysteine protease inhibitor E-64, which

enhanced chemokine and cytokine expression in 2-

blocks cathepsins, or the serine protease inhibitor

dimensional tissues. CCL3, CCL4, and CCL8 were

camostat mesylate, which blocks TMPRSS2 (and

selectively expressed in infected macrophages and

possibly TMPRSS4) (27). E-64 abolished SARS-CoV-2

CSF3, CXCL8, IL1B, and IL6 were induced in infected

infection of hPSC-derived cardiomyocytes as shown

ﬁbroblasts (Supplemental Figure 7).

by reduced NeonGreen expression and viral RNA

and

administered

either

the

IS

within the supernatant. Camostat had no effect on

MEDIATED BY ACE2 AND ENDOSOMAL CYSTEINE

cardiomyocyte infection over a range of doses that

PROTEASES. A neutralizing human ACE2 (viral re-

signiﬁcantly affect SARS-CoV-2 infection of lung-

ceptor) antibody abrogated SARS-CoV-2–NeonGreen

derived cell lines where TMPRSS2 mediates viral en-

infectivity as measured by NeonGreen-positivity and

try (17). Laboratory cultivated SARS-CoV-2 stocks

viral RNA extracted from the supernatant of infected

have acquired a mutation in the furin cleavage site,

cultures. The extent of blockade was comparable to

which alters the preference for proteases (TMPRSS2

treatment with remdesivir, a potent inhibitor of the

vs. cathepsins) that mediate SARS-CoV-2 entry

SARS-CoV-2 RNA-dependent RNA polymerase (24–26)

(27–29). To assess the impact this mutation on car-

(Supplemental Figure 8). After binding to ACE2, the

diomyocyte infectivity and entry, we inoculated

SARS-CoV-2

ENTRY

INTO

CARDIOMYOCYTES

spike protein must undergo proteolytic activation to

hPSC-derived cardiomyocytes with either wild-type

initiate membrane fusion (27). Host proteases located

SARS-CoV-2 or recombinant SARS-CoV-2 containing

at the plasma membrane (TMPRSS2) or within endo-

the furin cleavage site mutation ( D PRRA). Both vi-

somes (cathepsins) most commonly perform this

ruses readily infected cardiomyocytes through an

function. The relative contributions of each of these

endosomal-dependent

protease families to SARS-CoV-2 infection varies by

Figure 8).

mechanism

(Supplemental

cell type (17,27). hPSC-derived cardiomyocytes ex-

EHT MODEL COVID-19 MYOCARDITIS. To examine

press multiple endosomal proteases including ca-

whether SARS-CoV-2 infection of EHTs mimics as-

thepsins and calpains. Low levels of transmembrane

pects of COVID-19 myocarditis, we generated EHTs

protease, serene 2 (TMPRSS2) mRNA were detected in

containing hPSC-derived cardiomyocytes, ﬁbroblasts,

hPSC-derived cardiomyocytes, but not in ﬁbroblasts

and macrophages. EHTs were seeded in a collagen-

F I G U R E 5 Continued

(A) Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) stain (red) and cardiac actin (green) immunostaining of EHTs (CM þFb þ Mac) 5 days after
mock or SARS-CoV-2 infection (MOI 0.1). Blue: DAPI. Representative images from 4 independent experiments. (B) Quantiﬁcation of TUNEL-positive cells in areas of
viral infection. Error bars represent SE of the mean, *p < 0.05 compared to mock (Student t test). (C) Immunostaining of hPSC-derived cardiomyocytes for troponin T
(red) 3 days after inoculation with mock control or SARS-CoV-2–NeonGreen (MOI 0.1). Blue: DAPI. Arrows denote areas of sarcomere disassembly. (D) Immunostaining
of EHTs for troponin T (red) and SARS-CoV-2 nucleocapsid (green) 5 days after inoculation with mock control or SARS-CoV-2–NeonGreen (MOI 0.1). Blue: DAPI.
Arrows denote SARS-CoV-2 nucleocapsid–positive cells with reduced troponin T staining. (E) Quantiﬁcation of troponin T staining in mock (white) and SARS-CoV-2
infected (red) EHTs. Data is presented as mean ﬂorescence intensity (MFI). MFI was measured in infected (nucleocapsid-positive [NPþ]) cardiomyocytes and uninfected
(NP-) cardiomyocytes located proximal or remote to areas of infection. Error bars represent SE of the mean, *p < 0.05 compared to mock (Student t test). (F)
Quantitative RT-PCR measuring OAS1, MX1, and tumor necrosis factor (TNF) mRNA expression in hPSC-derived cardiomyocytes 3 days post-inoculation with mock
control (white) or SARS-CoV-2 (green, MOI 0.1). Cells were treated with vehicle, angiotensin-converting enzyme 2 antibody (ACE2 Ab) (20 mg/ml), remdesivir (10 mM),
or TBK inhibitor (MRT67307, 10mM). Error bars indicate SE of the mean. *p < 0.05 compared to mock control (Student t test). (G) Quantitative RT-PCR of SARS-CoV-2 N
gene expression in hPSC-derived cardiomyocytes that were either mock infected (white) or inoculated with SARS-CoV-2 (green, MOI 0.1) and harvested 3 days postinoculation. Error bars denote SE of the mean. Dotted line: limit of detection. *p < 0.05 compared to uninfected control (analysis of variance [ANOVA]) or vehicle
infected as indicated by the bar (ANOVA). (H,I) Flow cytometry measuring the percent of infected (H) and viable (I) cardiomyocytes following either mock infection
(white) or inoculation with SARS-CoV-2 (green, MOI 0.1). Cells were harvested and analyzed 3 days post-inoculation. Error bars denote SE of the mean. *p < 0.05
compared to uninfected control (ANOVA). (J) Quantitative RT-PCR measuring TNNT2 mRNA expression 3 days post-inoculation with mock control (white) or SARSCoV-2 (green, MOI 0.1). Error bars indicate SE of the mean. *p < 0.05 compared to mock control (ANOVA). (K) Immunostaining for troponin T (red) 3 days postinoculation with mock control or SARS-CoV-2–NeonGreen (MOI 0.1). Blue: DAPI. Arrows denote areas of sarcomere disassembly. Abbreviations as in Figures 1 and 2.
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Matrigel matrix between 2 PDMS posts, infected with

Remdesivir similarly reduced inﬂammatory gene

SARS-CoV-2, and harvested 5 days after inoculation.

expression in 3-dimensioinal EHTs (Supplemental

Hematoxylin and eosin staining revealed increased

Figure 11), establishing that viral infection repre-

interstitial cell abundance within the periphery of

sents the upstream driver of inﬂammation in our

SARS-CoV-2–infected EHTs (Figure 4A). Immuno-

model system.

staining for the viral nucleocapsid protein demon-

To examine the impact of cardiomyocyte inﬂam-

strated evidence of infected cardiomyocytes at the

matory signaling on cell death, sarcomere gene

periphery of the tissue, possible representing limited

expression, and sarcomere structure, we focused on

diffusion of the virus in the EHT environment. CD68

inhibiting viral nucleic acid sensing in 2-dimensional

immunostaining showed macrophage accumulation

cultures given their amenability to ﬂow cytometry

corresponding to sites of viral infection (Figure 4B,

and high-resolution imaging. TANK-binding kinase 1

Supplemental Figure 9). Infected EHTs accumulated

(TBK1) is an essential mediator of nucleic acid

high levels of viral RNA (Figure 4C). In situ hybridi-

sensing pathways including RIG-I, MAVS, STING, and

zation for viral spike sense and antisense RNA indi-

TLRs (31,32). Inhibition of TBK1 activity reduced type

cated active viral replication within EHTs (Figure 4D)

I IFN activity (inﬂammatory signature in infected

(Supplemental Figure 10).

cardiomyocytes) (Figure 3I) without impacting viral

As reduced LV systolic function has been reported

load,

cardiomyocyte

infectivity,

or

cell

death

in severe cases of COVID-19 myocarditis, we exam-

(Figures 5F to 5I). While TBK1 inhibition prevented

ined the effect of SARS-CoV-2 infection on EHT

reductions in TNNT2 and MYH7 mRNA expression

contractility (30). We calculated the average peak

following SARS-CoV-2 infection, sarcomere break-

displacement and velocity for each spontaneously

down remained prevalent. In contrast, remdesivir

contracting tissue (Videos 1 and 2). EHTs consisting of

prevented both reductions in TNNT2 and MYH7

hPSC-derived cardiomyocytes and ﬁbroblasts were

mRNA expression and sarcomere loss following

inoculated with SARS-CoV-2, and contractile function

SARS-CoV-2

analyzed

tissues

Supplemental Figure 11). These data indicate that

showed reduced contraction, speed of contraction,

sarcomeric disassembly and cardiomyocyte cell death

and relaxation relative to the mock-infected tissues

are the result of cardiomyocyte infection and not

(Figures 4E to 4G).

inﬂammation in the EHT system.

daily.

SARS-CoV-2–inoculated

infection

(Figures

5J,

5K,

and

To examine whether cardiomyocyte cell death
might serve as a mechanism explaining reduced

DISCUSSION

EHT contractility, we performed terminal deoxynucleotidyl transferase dUTP nick end labelling

Whether cardiac manifestations of COVID-19 are a

(TUNEL) staining and observed increased numbers

result of viral infection, systemic inﬂammation,

of TUNEL-positive cardiomyocytes in SARS-CoV-2–

and/or microvascular thrombosis remains a debated

infected EHTs on day 5 post infection (Figures 5A

topic. We examined myocardial specimens obtained

and 5B). Our RNA sequencing data suggested that

from individuals with severe COVID-19 myocarditis

other mechanisms also may contribute to reduced

and revealed evidence of cardiomyocyte infection,

EHT contractility, including sarcomere structure,

cell death, and macrophage inﬁltration. These ﬁnd-

metabolism,

responses

ings are consistent with prior reports highlighting

(Figure 3I). Immunostaining of hPSC-derived car-

inﬁltration of monocytes, lymphocytes, and plasma

diomyocytes infected with SARS-CoV-2 revealed

cells in an endomyocardial biopsy specimen from a

evidence of sarcomere loss 3 days following infec-

patient with suspected COVID-19 myocarditis and

tion (Figure 5C), a time point that preceded cell

viral RNA within the myocardium of COVID-19 au-

death. Immunostaining of EHTs showed reduced

topsy specimens (33,34). The specimens examined in

troponin T expression in infected cardiomyocytes

this study differ substantially from published autopsy

(Figures 5D and 5E).

series, which did not include subjects with cardiac

and/or

host

immune

We then examined the mechanistic relationship

manifestations (3,35). Here, we exclusively focused

inﬂammatory

on subjects with COVID-19 infection and severe

signaling, sarcomere loss, and cell death. Inhibition of

myocarditis based on echocardiography and clinical

viral entry (ACE2 neutralizing antibody) or viral

presentation.

between

cardiomyocyte

infection,

replication (remdesivir) was sufﬁcient to prevent type

We further provide evidence that SARS-CoV-2 in-

I IFN and tumor necrosis factor (TNF) expression

fects and replicates within human cardiomyocytes.

following SARS-CoV-2 infection (Figures 5F and 5G).

SARS-CoV-2 was unable to replicate in cardiac
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ﬁbroblasts, endothelial cells, and macrophages. It

EHTs provided an opportunity to gain insights into

remains possible that SARS-CoV-2 could also infect

the relationship between cardiomyocyte infection,

other cardiac cell types that are difﬁcult to isolate

myocardial inﬂammation, and contractile dysfunc-

from the human heart such as pericytes and endo-

tion. Infection of EHTs resulted in inﬂammatory

cardial cells. Despite these limitations, our ﬁndings

mediator generation, decreased ACE2 expression,

clearly show that cardiomyocytes are a target of

cardiomyocyte cell death, sarcomere breakdown, and

SARS-CoV-2 infection.

reduced sarcomeric and metabolic gene expression.

To gain insights into the mechanistic basis of

Each of these mechanisms likely contributes to

we

diminished EHT contractility. We showed that car-

developed a human EHT system that recapitulates

diomyocyte infection triggers inﬂammatory gene

features of SARS-CoV-2–induced myocarditis. We

expression, sarcomere loss, and cell death. Blockade

provide evidence that SARS-CoV-2 infects hPSC-

of viral nucleic acid sensing pathways did not prevent

derived

reduced

sarcomere disassembly or cardiomyocyte cell death.

metabolic and contractile apparatus gene expres-

Despite the limitations of the inherent immaturity of

sion,

inﬂammatory

hPSC-derived cardiomyocytes and incomplete repre-

signaling, and cell death. Viral entry was ACE2-

sentation of human myocardial cell types included in

cardiomyocyte

infection

and

cardiomyocytes,
sarcomeric

myocarditis,

resulting

disassembly,

in

dependent and relied on endosomal cysteine pro-

EHTs, these ﬁndings highlight the central role of

tease activity. Our ﬁndings are consistent with a

cardiomyocyte infection and suggest that targeting

recent report suggesting that SARS-CoV-2 infects

viral cell entry, replication, or sarcomere breakdown

human cardiac slices, hPSC-derived cardiomyocytes

may improve outcomes in patients with cardiac

in an ACE2 and cathepsin-dependent manner, and

complications of COVID-19. The relevance of ACE2

impacts the beating of cardiospheres (36). We

downregulation

extend

require further clariﬁcation as Ace2 -/- mice display LV

these

observations

to

show

that

car-

in

infected

cardiomyocytes

will

diomyocytes supported viral replication, rapidly

systolic dysfunction and heart failure (41).

produced infectious virions, activated type I IFN

STUDY LIMITATIONS. While our ﬁndings implicate

signaling, and displayed cytopathic features seen

that SARS-CoV-2 cardiomyocyte infection likely con-

with coronavirus infection. Infected EHTs showed

tributes to myocardial dysfunction, our ﬁndings do

reduced contractile force, sarcomere disassembly,

not exclude an important role for inﬂammation or

and pathological evidence of myocarditis including

microthrombi in COVID-19 cardiac pathology. Mac-

macrophage activation.

rophages and ﬁbroblasts likely contribute to the in-

Extrapulmonary cell types are susceptible to

ﬂammatory response. Despite resistance to SARS-

SARS-CoV-2 infection (37–39). This broader cellular

CoV-2 infection, macrophages and ﬁbroblasts gener-

tropism is dictated by ACE2 expression and the

ated inﬂammatory mediators when exposed to SARS-

ability of the virus to gain access to extrapulmo-

CoV-2. This response could be a result of direct

nary tissues. Whether SARS-CoV-2 enters the heart

recognition of viral RNAs and proteins or communi-

through

direct

cation with infected cardiomyocytes through pro-

extension from the pleural cavity remains un-

duction of soluble mediators or intercellular transfer

known.

car-

via gap junctions. Future studies are necessary to

diomyocytes and pericytes express ACE2 mRNA

dissect the cellular mechanisms and signaling path-

hematological
Among

seeding

myocardial

cell

and/or
types,

(19). Cardiac ﬁbroblasts and vascular smooth muscle cells may also express ACE2 (20). We showed
that

ACE2

is

preferentially

expressed

in

ways that initiate and convey the adverse impact of
myocardial inﬂammation.

car-

diomyocytes and is essential for SARS-CoV-2 to

CONCLUSIONS

infect cardiomyocytes. It remains to be explored
whether cardiomyocyte maturation or remodeling

This study provides evidence that cardiomyocytes

impact vulnerability to viral infection. This possi-

are a target of SARS-CoV-2 in the human heart and

bility is supported by the heterogeneous expression

support the conclusion that SARS-CoV-2 infection of

of ACE2 in the human heart and may explain why

cardiomyocytes and resultant myocardial injury and

pre-existing

inﬂammation contribute to the cardiac manifesta-

cardiovascular

disease

represents

a

strong risk factor for COVID-19 mortality. Consis-

tions

tent with this idea, ACE2 expression is increased in

infection of 2-dimensional cultures and EHTs re-

of

COVID-19.

We

show

that

SARS-CoV-2

heart failure (30,40).

sults in reductions in cardiac contractility through
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sarcomere breakdown, disruption of metabolic gene

reported that they have no relationships relevant to the contents of

expression, and cardiomyocyte death. Collectively,

this paper to disclose.

these ﬁndings show that SARS-CoV-2 can productively infect human cardiomyocytes and establish
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